Authors:
Pallis, M
Grundy, M
Turzanski, J
Kofler, R
Russell, N
Citation: M. Pallis et al., Mitochondrial membrane sensitivity to depolarization in acute myeloblasticleukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status, BLOOD, 98(2), 2001, pp. 405-413
Citation: Nr. Lewis et al., Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia, EXP HEMATOL, 28(5), 2000, pp. 535-542
Authors:
Higashi, Y
Turzanski, J
Pallis, M
Russell, NH
Citation: Y. Higashi et al., Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia, BR J HAEM, 111(2), 2000, pp. 565-569
Citation: M. Pallis et N. Russell, P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of asphingomyelin-ceramide apoptotic pathway, BLOOD, 95(9), 2000, pp. 2897-2904
Citation: M. Pallis et N. Russell, P-glycoprotein expression is associated with resistance to spontaneous in vitro apoptosis in AML, LEUKEMIA, 13(9), 1999, pp. 1468-1469
Authors:
Byrne, JL
Dasgupta, E
Pallis, M
Turzanski, J
Forman, K
Mitchell, D
Haynes, AP
Russell, NH
Citation: Jl. Byrne et al., Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG, LEUKEMIA, 13(5), 1999, pp. 786-791
Citation: M. Pallis et al., Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: The use of 7AAD with antibodies to CD45 or CD34, CYTOMETRY, 37(4), 1999, pp. 308-313
Authors:
Pallis, M
Turzanski, J
Harrison, G
Wheatley, K
Langabeer, S
Burnett, AK
Russell, NH
Citation: M. Pallis et al., Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia, BR J HAEM, 104(2), 1999, pp. 307-312